Fiona M McQueen

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. McQueen F, Solanki K. Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?. Rheumatology (Oxford). 2015;54:757-67 pubmed publisher
    ..We have also reviewed the parallels between SSc and the other CTDs where B-cell depletion therapy is efficacious. ..
  2. request reprint
    McQueen F, Dalbeth N, Doyle A. MRI in psoriatic arthritis: insights into pathogenesis and treatment response. Curr Rheumatol Rep. 2008;10:303-10 pubmed
    ..Finally, MRI can be used to score and quantify these pathologic features, providing a sensitive tool with which to evaluate disease progression. ..
  3. McQueen F, Lloyd R, Doyle A, Robinson E, Lobo M, Exeter M, et al. Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study. Ann Rheum Dis. 2011;70:1091-4 pubmed publisher
    ..In this pilot study ZA reduced the progression of MRI bone oedema, indicating probable suppression of osteitis concordant with reduction in clinical measures of disease activity. ..
  4. McQueen F, Doyle A, Reeves Q, Gao A, Tsai A, Gamble G, et al. Bone erosions in patients with chronic gouty arthropathy are associated with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study. Rheumatology (Oxford). 2014;53:95-103 pubmed publisher
    ..9), P < 0.0001]. Erosions were strongly associated with tophi but not bone oedema or synovitis. MRI bone oedema was relatively uncommon and low grade. These findings highlight the unique nature of the osteopathology of gout. ..
  5. McQueen F, Clarke A, McHaffie A, Reeves Q, Williams M, Robinson E, et al. Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis. 2010;69:1971-5 pubmed publisher
    ..68 to 0.78). This MRI cartilage score demonstrated excellent reliability when tested in a three-reader system. However, cartilage loss in early RA could not be distinguished from that seen in healthy controls. ..
  6. McQueen F. Rheumatology around the world: perspectives from Australia and New Zealand. Arthritis Res Ther. 2017;19:24 pubmed publisher
    ..We are fortunate in having world-class rheumatology research in our region with basic scientists and clinical rheumatologists spearheading investigations, the ultimate aim of which is to improve the quality of life for our patients. ..
  7. request reprint
    McQueen F, Beckley V, Crabbe J, Robinson E, Yeoman S, Stewart N. Magnetic resonance imaging evidence of tendinopathy in early rheumatoid arthritis predicts tendon rupture at six years. Arthritis Rheum. 2005;52:744-51 pubmed
    ..High scores in early disease were predictive of tendon rupture in a small group of patients, but further studies are required to determine whether this has clinical relevance. ..
  8. McQueen F, Gao A, Ostergaard M, King A, Shalley G, Robinson E, et al. High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann Rheum Dis. 2007;66:1581-7 pubmed
    ..There was concordance between the presence and severity of MRI bone oedema and osteitis on histology, with an MRI threshold effect due to differences in image resolution. ..
  9. McQueen F. The MRI view of synovitis and tenosynovitis in inflammatory arthritis: implications for diagnosis and management. Ann N Y Acad Sci. 2009;1154:21-34 pubmed publisher
    ..In the long term, an overall score of inflammation incorporating synovitis, tenosynovitis, and bone edema may be a more useful MRI predictor of aggressive erosive disease...

More Information

Publications11

  1. McQueen F, Reeves Q, Dalbeth N. New insights into an old disease: advanced imaging in the diagnosis and management of gout. Postgrad Med J. 2013;89:87-93 pubmed publisher
    ..This review discusses the clinical and research applications of advanced imaging in gout with particular focus on diagnosis and monitoring of joint inflammation and damage...
  2. McQueen F, Chapman P, Pollock T, D Souza D, Lee A, Dalbeth N, et al. Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis. Arthritis Res Ther. 2017;19:241 pubmed publisher
    ..The association was significant but relatively weak, suggesting that MRI targets cannot yet be advocated as outcomes for T2T escalation. ANZCTR 12614000895684 . Registered 22 August 2014. ..